Clinical Trial Update: Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial of TRK-700 for post-herpetic neuralgia has completed, reporting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-herpetic Neuralgia

Drugs mentioned

• TRK-700

Snippet

Sponsor: Toray Industries, Inc | Conditions: Post-Herpetic Neuralgia | Phase 2 | Status: COMPLETED